UR9A Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Clinuvel Pharmaceuticals Ltd

Watchlist Manager

Watchlist

Price: 4.16 EUR -5.02% Market Closed

Market Cap: €208.5m

	Clinuvel Pharmaceuticals Ltd F:UR9A	AU
	Agora Inc NASDAQ:API	US
	Easterly Government Properties Inc NYSE:DEA	US
S	SSE PLC F:SCT	UK
X	Xilam Animation SA F:XIH	FR
A	Abacore Capital Holdings Inc XPHS:ABA	PH
C	Chugai Pharmaceutical Co Ltd XMUN:CUP	JP
S	Sensirion Holding AG SIX:SENS	CH
K	Kajima Corp F:KAJ	JP
	SRP Groupe SA PAR:SRP	FR
E	Eli Lilly and Co DUS:LLY	US
	Banque Cantonale Vaudoise SIX:BCVN	CH
I	Investec PLC LSE:INVR	UK

Profitability Summary

Clinuvel Pharmaceuticals Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

83%

Strong 3Y Average Gross Margin

95%

Declining Gross Margin

94% > 83%

Exceptional Operating Margin

43%

Strong 3Y Average Operating Margin

51%

Declining Operating Margin

56% > 43%

Exceptional Net Margin

36%

Strong 3Y Average Net Margin

38%

Declining Net Margin

39% > 36%

Exceptional Free Cash Flow Margin

38%

Strong 3Y Average Free Cash Flow Margin

38%

Declining Free Cash Flow Margin

46% > 38%

Positive ROE

13%

Positive 3Y Average ROE

Exceptional 3Y Average ROIC

104%

Declining ROIC

122% > 81%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.